Report: The FDA is aiming for final approval of the Pfizer vaccine by Labor Day

The Food and Drug Administration is aiming to fully approve the Pfizer-BioNTech COVID-19 vaccine by Labor Day or sooner, people familiar with the matter told The New York Times.

Because of the highly contagious Delta variant, coronavirus cases are on the rise across the United States, and the hope is that a full approval will push skeptics to get inoculated. In late 2020, the FDA granted emergency authorization to the Pfizer vaccine, and the company applied for full approval on May 7. Moderna also received emergency authorization for its vaccine, and submitted its application for final approval on June 1.

As part of the approval process, FDA employees will review hundreds of thousands of documents, looking at data on vaccine efficacy, immune responses, and breakthrough infections. Once a coronavirus vaccine is fully approved, it's expected that many schools and hospitals, as well as the city of San Francisco and the Department of Defense, will mandate that workers and students get vaccinated, the Times reports. As of Tuesday, 58 percent of Americans have received at least one dose of a COVID-19 vaccine.

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up